Upload
nguyenphuc
View
217
Download
0
Embed Size (px)
Citation preview
205
BIBLIOGRAPHY:
1. Aller, A.I., Martin-Mazuelos, E., Lozano, F., Gomez-Mateos, J., Steele-Moore, L. and
Holloway, W.J. (2000). Correlation of fluconazole MICs with clinical outcome in
cryptococcal infection. Antimicrob. Agent. Chemother. 44:1544–1548.
2. Ananthanarayan, R. and Paniker, C.K.J. (2000). Textbook of Microbiology. 6th ed.
Mumbai: Orient Longman publishers. 178-199.
3. Aoki, S., Ito Kuwa, S., Nakamura, K., Ninomiya, K. and Vidotto, V. (1994). Extracellular
proteolytic activity of Cryptococcus neoformans. Mycopathol. 128:143-150.
4. Averbuch, D., Boekhout, T., Falk, R., Engelhard, D., Shapiro, M., Block, C. and
Polacheck, I. (2002). Fungemia in a cancer patient caused by fluconazole-resistant
Cryptococcus laurentii. Med. Mycol. 40:479-484.
5. Banerjee, U. (2005). Progress in diagnosis of opportunistic infections in HIV/AIDS. Ind.
J. Med. Res. 121:395-406.
6. Barnard, J.P. and Stinson, M.W. (1996). The alpha-hemolysin of Streptococcus gordonii
is hydrogen peroxide. Infect. Immun. 64:3853–3857.
7. Baro, T., Torres-Rodriguez, J.M., Mendoza, M.H., Morera, Y. and Alia, C. (1998). First
identification of autochronous Cryptococcus neoformans var. gattii isolated from goats
with predominantly severe pulmonary disease in Spain. J. Clin. Microbiol. 36:458-461.
8. Barrett-Bee, K., Hayes, Y., Wilson, R.G. and Ryley, J.F. (1985). A comparison of
phospholipase activity, cellular adherence and pathogenicity of yeasts. J. Gen. Microbiol.
131:1217-1221.
9. Bauters, T.G., Swinne, D., Boekhout, T., Noens, L. and Nelis, H.J. (2002). Repeated
isolation of Cryptococcus laurentii from the oropharynx of an immunocompromised
patient. Mycopathol. 153:133-135.
206
10. Benham, R.W. (1935). Cryptococci-their identification by morphology and by serology. J.
Infect. Dis. 57:255-274.
11. Benham, R.W. (1950). Cryptococcosis and blastomycosis. Ann. N. Y. Acad. Sci.
50:12991314.
12. Bergey, D.H., Holt, J.G., Krieg, N.R. and Sneath, P.H.A. (1994). Bergey's Manual of
Determinative Bacteriology. 9th ed. Lippincott Williams & Wilkins.
13. Bernal-Martinez, L., Gomez-Lopez, A., Castelli, M.V., Mesa-Arango, A.C., Zaragoza, O.
and Rodriguez-Tudela, J.L. (2010). Susceptibility profile of clinical isolates of
nonCryptococcus neoformans/non-Cryptococcus gattii Cryptococcus species and
literature review. Med. Mycol. 48:90–96.
14. Boddy, L. and Frankland, J.C. (2008). Ecology of saprotrophic basidiomycetes. British
Mycological Society Symposium Series. London: Elsevier Science.
15. Bowles, D.B. and Fry, D.R. (2009). Nasal cryptococcosis in two dogs in New Zealand. N.
Z. Vet. J. 57:53-57.
16. Breen, J.F., Lee, I.C., Vogel, F.B. and Friedman, H. (1982). Cryptococcal capsular
polysaccharide-induced modulation of murine immune response. Infect. Immun. 36:47-51.
17. British Columbia Centre for Disease Control (CDC-2008). BC Cryptococcus gattii
Surveillance Summary. 1999-2006.
18. Brueske, C.H. (1986). Proteolytic activity of a clinical isolate of Cryptococcus neoformans.
J. Clin. Microbiol. 23:631-633.
19. Casadevall, A. and Perfect, J.R. (1998). Cryptococcus neoformans. Washington, D.C.:
ASM Press.
207
20. Casali, A.K., Goulart, L. and Silva, L.K.R. (2003). Molecular typing of clinical and
environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul.
FEMS Yeast Res. 33: 405–415.
21. Cazin, J.R., Kozel, T.R., Lupan, D.M. and Burt, W.R. (1969). Extracellular
deoxyribonuclease production by yeasts. J. bacteriol. 100:760-762.
22. Chakrabarti, A., Jatana, M., Kumar, P., Chatha, L. and Padhye, A.A. (1997). Isolation of
Cryptococcus neoformans var. gattii from Eucalyptus camaldulensis in India. J. Clin.
23. Microbiol. 35:3340-3342.
24. Chakrabarti, A., Singh, K. and Jatana, M. (1998). Medical Mycology Laboratory
Procedures: International Workshop on Medical Mycology. Department of Medical
Microbiology, PGIMER, Chandigarh, India.
25. Chander, J. (2009). A text book of Medical Mycology. 3rd ed. Delhi: Mehta Publishers.
231-249.
26. Chaskes, S. and Tyndall, R.L. (1978a). Pigment production by Cryptococcus neoformans
and other Cryptococcus species from aminophenols and diaminobenzenes. J. Clin.
Microbiol. 7:146-152.
27. Chaskes, S. and Tyndall, R.L. (1978b). Pigmentation and auto fluorescence of
Cryptococcus species after growth on tryptophan and anthranilic acid media. Mycopathol.
64:105–112.
28. Chaskes, S., Edberg, S.C. and Singer, J.M. (1981). A DL-DOPA drop test for the
identification of Cryptococcus neoformans. Mycopathol. 74:143–148.
29. Chaskes, S., Frases, S., Cammer, M., Gerfen, G. and Casadevall, A. (2008). Growth and
pigment production on D-Tryptophan medium by Cryptococcus gattii, Cryptococcus
neoformans and Candida albicans. J. Clin. Microbiol. 46: 255-264.
208
30. Chayakulkeeree, M. and Perfect, J.R. (2006). Cryptococcosis. Infect. Dis. Clin. N. Am.
20: 507-544.
31. Chen, S.C.A., Muller, M., Zhou, J.U., Wright, L.C. and Sorell, T.C. (1997). Phospholipase
activity in Cryptococcus neoformans: a new virulence factor? J. Infect. Dis. 175:414-420.
32. Chen, S.C.A., Wright, L.C., Golding, J.C. and Sorrell, T.C. (2000). Purification and
characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/
transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans.
33. Biochem. Jour. 347:431–439.
34. Cheng, M.F., Chiou, C.C., Liu, Y.C., Wang, H.Z. and Hsieh, K.S. (2001). Cryptococcus
laurentii fungemia in a premature neonate. J. Clin. Microbiol. 39:1608-1611.
35. Cherniak, R. and Sundstrom, J.B. (1994). Polysaccharide antigens of the capsule of
Cryptococcus neoformans. Infect. Immun. 62:1507-1512.
36. Colom, M.F. and Ferrer, C. (2005). First case of human cryptococcosis due to
Cryptococcus neoformans var. gattii in Spain. J. Clin. Microbiol. 43: 3548-3550.
37. Costa, A.K., Sidrim, J.J., Cordeiro, R.A., Brilhante, R.S., Monteiro, A.J. and Rocha, M.F.
(2010). Urban pigeons (Columba livia) as a potential source of pathogenic yeasts: a focus
on antifungal susceptibility of Cryptococcus strains in Northeast Brazil. Mycopathol.
169:207–213.
38. Cox, L.B. and Tolhurst, J.C. (1946). Human Torulosis. Melbourne University Press,
Melbourne, Australia.
39. Currie, B.P. and Casadevall, A. (1994). Restriction Fragment Length Polymorphism
analysis of Cryptococcus neoformans from environmental and clinical sources in New
York City. J. Clin. Microbiol. 32:1188-1192.
40. Donlan, R.M. (2002). Biofilms: microbial life on surfaces. Emerg. Infect. Dis. 8:881–890.
209
41. Dromer, F., Moulignier, A. and Dupont, B. (1995). Myeloradiculitis due to Cryptococcus
curvatus in AIDS. AIDS. 9:395–396.
42. Drouhet, E. (1997). Milestones in the history of Cryptococcus and cryptococcosis. J.
43. Mycol. Md. 7:10-27.
44. Dufait, R., Velho, R. and Vroey, C. (1987). Rapid identification of the two varieties of
Cryptococcus neoformans by D-proline assimilation. Mykosen. 30:483.
45. Duncan, C., Schwantje, H., Stephen, C., Campbell, J. and Bartlett, K. (2006a).
Cryptococcus gattii in wildlife of Vancouver Island, British Columbia, Canada. J. Wild. L.
Dis. 42:175-178.
46. Duncan, C.G., Stephen, C. and Campbell, J. (2006b). Evaluation of risk factors for
Cryptococcus gattii infection in dogs and cats. J. Amer. Vet. Med. Assoc. 228:377-382.
47. Edwards, P.R. and Ewing, W.H. (1972). Identification of enterobacteriaceae. 3rd ed.
48. Minneapolis: Burgess Publishing Co.
49. Eisenman, H.C., Mues, M., Weber, S.E., Frases, S., Chaskes, S., Gerfen, G. and
Casadevall, A. (2007). Cryptococcus neoformans laccase catalyses melanin synthesis from
both D and L-DOPA. Microbiol. 153: 3954–3962.
50. Eissenberg, L.G., Poirier, S. and Goldman, W.E. (1996). Phenotypic variation and
persistence of Histoplasma capsulatum yeasts in host cells. Infect. Immun. 64:5310–5314.
51. Ellis, D.H. and Pfeiffer, T.J. (1990). Natural habitat of Cryptococcus neoformans var.
52. gattii. J. Clin. Microbiol. 28:1642-1644.
53. Emmons, C.W. (1955). Saprophytic sources of Cryptococcus neoformans associated with
the pigeon (Columba livia). Am. J. Hyg. 62:227.
54. Emmons, C.W. (1960). Prevalence of Cryptococcus neoformans in pigeon habitats. Public
Health Report. 75:362-364.
210
55. Emmons, C.W. (1951). Isolation of Cryptococcus neoformans from soil. National
Microbiological Institute, Bethesda, Maryland.
56. Ergin, C. and Lkit, M. (2004). Detection of Cryptococcus neoformans var. grubii in
honeybee colonies. Mycoses. 47:431-434.
57. Escandon, P., Sanchez, A., Martinez, M., Meyer, W. and Castaneda, E. (2006). Molecular
epidemiology of clinical and environmental isolates of the Cryptococcus neoformans
species complex reveals a high genetic diversity and the presence of the molecular type
VGII mating type a in Colombia. FEMS Yeast Res. 6:625-635.
58. Fazekas, G. and Schwarz, J. (1958). Histology of experimental murine cryptococcosis. Am.
J. Pathol. 34:517–529.
59. Felsenstein, J. (1985). Confidence limits on phylogenies: An approach using the bootstrap.
Evolution. 39:783-791.
60. Feng, X., Yao, Z. and Ren, D. (2008). Simultaneous identification of molecular and mating
types within the Cryptococcus species complex by PCR-RFLP analysis. J. Med. Microbiol.
57:1481-1490.
61. Findley, K., Rodriguez-Carres, M., Metin, B., Kroiss, J., Fonseca, A., Vilgalys, R. and
Heitman, J. (2009). Phylogeny and phenotypic characterization of pathogenic
Cryptococcus species and closely related saprobic taxa in the tremellales. Eukar. Cell.
8:353–361.
62. Franzot, S., Hamdan, J., Currie, B.P. and Casadevall, A. (1997). Molecular Epidemiology
of Cryptococcus neoformans in Brazil and the United States: evidence for both local
genetic differences and a global clonal population structure. J. Clin. Microbiol. 35:2243-
2251.
63. Franzot, S., Mukherjee, J., Cherniak, R., Chen, L., Hamdan, J. and Casadevall, A. (1998).
Microevolution of a standard strain of Cryptococcus neoformans resulting in differences
in virulence and other phenotypes. Infect. Immun. 66:89–97.
211
64. Freeman, W. (1931). Torula infection of the central nervous system. J. Psycho. Neurol.
43:236-345.
65. Fromptling, R.A., Shadomy, H.K. and Jacobson, E.S. (1982). Decreased virulence in stable
acapsular mutants of Cryptococcus neoformans. Mycopathol. 79:23–29.
66. Fyfe, M., MacDougall, L., Romney, M., Starr, M., Pearce, M. and Mak, S. (2008). C. gattii
infections on Vancouver Island, British Columbia, Canada: emergence of a tropical fungus
in a temperate climate. Can. Commun. Dis. Rep. 34:1-13.
67. Galanis, E. and MacDougall, L. (2010). Epidemiology of Cryptococcus gattii, British
Columbia, Canada, 1999-2007.Emerg. Infect. Dis. 16:251-257.
68. Garelick, J.M., Khodabakhsh, A.J., Lopez, Y., Bamji, M. and Lister, M. (2004). Scleral
ulceration caused by Cryptococcus albidus in a patient with acquired immune deficiency
syndrome. Cornea. 23:730-731.
69. Gluck, J.L., Myers, J.P. and Pass, L.M. (1987). Cryptococcemia due to Cryptococcus
albidus. South. Med. J. 80:511-513.
70. Goerke, I. (1974). Lung surfactant. Biochim. Biophys. Acta. 344:241-261.
71. Goldman, D., Lee, S.C. and Casadevall, A. (1994). Pathogenesis of pulmonary
Cryptococcus neoformans infection in the rat. Infect. Immun. 62:4755–4761.
72. Granados, D.P. and Castaneda, E. (2005). Isolation and characterization of Cryptococcus
neoformans varieties recovered from natural sources in Bogota, Colombia and study of
ecological conditions in the area. Microb. Ecol. 49:282-290.
73. Grover, N., Nawange, S.R., Naidu, J., Singh, S.M. and Sharma, A. (2007). Ecological niche
of Cryptococcus neoformans var. grubii and Cryptococcus gattii in decaying wood of trunk
hollows of living trees in Jabalpur City of Central India. Mycopathol.164:159170.
212
74. Guerrero, A., Jain, N., Goldman, D.L. and Fries, B.C. (2006). Phenotypic switching in
Cryptococcus neoformans. Microbiol. 152:3–9.
75. Halliday, C. and Carter, D.A. (2003). Clonal reproduction and limited dispersal in an
environmental population of Cryptococcus neoformans var. gattii isolates from Australia.
J. Clin. Microbiol. 41:703-711.
76. Hillis, D.M. and Dixon, M.T. (1991). Ribosomal DNA: molecular evolution and
phylogenetic inference. Quart. Rev. Biol. 66: 411-453.
77. Himachal Pradesh State AIDS Control Society. Available from: http://hpsacs.org/aids.asp
78. Hopfer, R.L. and Blank, F. (1975a). Caffeic acid-containing medium for identification of
Cryptococcus neoformans. J. Clin. Microbiol. 2: 115-120.
79. Hopfer, R.L. and Groschel, D. (1975b). Six-Hour pigmentation test for the identification
of Cryptococcus neoformans. J. Clin. Microbiol. 2:96-98.
80. Horowitz, I.D., Blumberg, E.A. and Krevolin, L. (1993). Cryptococcus albidus and
mucormycosis empyema in a patient receiving hemodialysis. South. Med. J. 86:10701072.
81. Hull, C.M. and Heitman, J. (2002). Genetics of Cryptococcus neoformans. Ann. Rev.
Genet. 36:557-615.
82. Huppert, M., Harper, G., Sun, S.H. and Delanerolle, V. (1975). Rapid methods for
identification of yeasts. J. Clin. Microbiol. 2:21-34.
83. Ibrahim, A.S., Mirbod, F. and Filler, S.G. (1995). Evidence implicating phospholipase as
a virulence factor of Candida albicans. Infect. Immun. 63: 1993-1998.
84. Ikeda, R. and Maeda, T. (2004). Structural studies of the capsular polysaccharide of a non-
neoformans Cryptococcus species identified as C. laurentii, which was reclassified as
Cryptococcus flavescens, from a patient with AIDS. Carbohydr. Res. 339:503-509.
213
85. Irokanulo, E.A.O., Akueshi, C.O. and Makinde, A.A. (1994). Differentiation of
Cryptococcus neoformans serotypes A and D using creatinine dextrose bromothymol blue
thymine medium.Br. J. Biomed. Sci. 51:100-103.
86. Jacobson, E.S. and Tinnell, S.B. (1993). Antioxidant functions of fungal melanin. J.
Bacteriol. 175:7102-7104.
87. Jain, M., Keller, M., Ragan, M.A. and Fries, B.C. (2005). Molecular epidemiology of
clinical C. neoformans strains from India. Ind. J. Clin. Microbiol. 43:5733-5742.
88. Jaiswal, S.P., Hemwani, N., Sharma, N., Athale, S. and Chitnis, D.S. (2002). Prevalence
of fungal meningitis, among HIV positive and negative subjects. Ind. J. Med. Sci.
56:325329.
89. Kabasawa, K., Itagaki, H., Ikeda, R., Shinoda, T., Kagaya, K. and Fukazawa, Y. (1991).
Evaluation of a new method for identification of Cryptococcus neoformans which uses
serologic tests aided by selected biological tests. J. Clin. Microbiol. 29:2873-2876.
90. Kantarcioglu, A.S., Boekhout, T., Hoog, G., Theelen, B., Yucel, A., Ekmekci, T.R., Fries,
B.C., Ikeda, R., Koslu, A. and Altas, K. (2007). Subcutaneous cryptococcosis due to
Cryptococcus diffluens in a patient with sporotrichoid lesions case report features of the
case isolate and in vitro antifungal susceptibilities. Med. Mycol. 45:173–181.
91. Katzu, M., Kidd, S., Ando, A., Moretti-Branchini, M.L., Mikami, Y., Nishimura, K. and
Meyer, W. (2003). The internal transcribed spacers and 5.8S rRNA gene show extensive
diversity among isolates of the Cryptococcus neoformans species complex. FEMS Yeast
Res. 4: 377-388.
92. Kaufman, L. and Blumer, S. (1977). Cryptococcosis: the awakening giant, abstr. 176182.
Proceedings of the Fourth International Conference on the Mycoses. PAHO Scientific
Publication No. 356.
214
93. Khan, Z.U., Ahmad, S., Mokaddas, E. and Chandy, R. (2004). Simplified sunflower seed
agar for differentiation of Candida dubliniensis from Candida albicans. Clin. Microbiol.
Infect. 10:590–592.
94. Kidd, S.E. and Hingston, O. (2007a). Cryptococcus gattii dispersal mechanisms, British
Columbia, Canada. Emerg. Infect. Dis. 13: 51-57.
95. Kidd, S.E. and Mak, S. (2007b). Characterization of environmental sources of the human
and animal pathogen Cryptococcus gattii in British Columbia, Canada and the Pacific
Northwest of the United States. App. Env. Microbiol. 73: 1433-1443.
96. Kidd, S.E., Hagen, F., Tscharke, R.L., Huynh, M., Bartlett, K.H., Fyfe, M. and Meyer, M.
(2004). A rare genotype of C. gattii caused the cryptococcosis outbreak on Vancouver
Island (BC, Canada).PNAS USA. 101:17258-17263.
97. Klein, K.R., Hall, L., Dem, S.M., Rysavy, J.M., Wohlfiel, S.L. and Wengenack, N.L.
(2009). Identification of Cryptococcus gattii by use of L-Canavanine Glycine
Bromothymol Blue medium and DNA sequencing. J. Clin. Microbiol. 47: 3669–3672.
98. Knoke, M. and Schwesinger, G. (1994). One hundreds years ago: the history of
cryptococcosis in Greifswald. Medical mycology in the nineteenth century. Mycoses.
37:229-233.
99. Kwon-Chung, K.J. (1975). A new genus, Filobasidiella, the perfect state of Cryptococcus
neoformans. Mycologia. 67:1197-1200.
100. Kwon-Chung, K.J. and Rhodes, J.C. (1986). Encapsulation and melanin formation as
indicators of virulence in Cryptococcus neoformans. Infect. Immun. 51:218–223.
101. Kwon-Chung, K.J., Bennett, J.E. and Theodore, T.S. (1978). Cryptococcus bacillisporus
sp. Nov.: serotype B-C of Cryptococcus neoformans. Int. J. Syst. Bacteriol. 28:616-620.
102. Kwon-Chung, K.J., Polacheck, I. and Bennett, J.E. (1982). Improved diagnostic medium
for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and
Cryptococcus neoformans var. gattii (serotypes B and C). J. Clin. Microbiol. 15: 535537.
215
103. Kwon-Chung, K.J., Wickes, B.L., Booth, J.L., Vishniac, H.S. and Bennett, J.E. (1987).
Urease inhibition by EDTA in the two varieties of Cryptococcus neoformans. Infect.
Immun. 55:1751-1754.
104. Laboratory methods (University of British Columbia (UBC), Canada). Available from:
http://cryptogattii.spph.ubc.ca/cryptococcus-gattii/labratory-methods.
105. Landlinger, C., Willinger, B. and Racil, Z. (2009). Species-specific identification of wide
range of clinical relevant fungal pathogens by use of Luminex xMAP technology. J. Clin.
Microbiol. 47:1063-1073.
106. Larone, D.H. (1987). Medically important fungi: a guide to identification. 2nd ed.
Amsterdam: Elsevier Science.53-84.
107. Leck, A. (1999). Corneal Ulcer. Community Eye Health. 12:24.
108. Linares, C.E.B., Loreto de, S.E., Silveira, C.P., Pozzatti, P., Scheid, L.A., Santurio, J.M.
and Alves, S.H. (2007). Enzymatic and hemolytic activities of Candida dubliniensis
strains. Rev. Inst. Med. Trop. 49:203-206.
109. Littman, M.L. (1947). A culture medium for the primary isolation of fungi. Science.
106:109-111.
110. Litvintseva, A.P., Vilgalys, R. and Mitchell, T.G. (2005). Comparative analysis of
environmental and clinical populations of Cryptococcus neoformans. J. Clin. Microbiol.
43:556-564.
111. Liu, G.Y. and Nizet, V. (2009). Color me bad: microbial pigments as virulence factors.
Trend. Microbiol. 17: 406–413.
216
112. Loperena, A. and Bopp, D.J. (2010). Genotypic characterization of environmental
isolates of Cryptococcus gattii from Puerto Rico. Mycopathol. 170: 279-285.
113. Luo, G., Samaranayake, L.P. and Yau, J.Y. (2001). Candida species exhibit differential
in vitro hemolytic activities. J. Clin. Microbiol. 39: 2971-2974.
114. MacDougall, L., Fyfe, M., Romney, M., Starr, M. and Galanis, E. (2011). Risk factors
for Cryptococcus gattii infection, British Columbia, Canada. Emerg. Infect. Dis. 17:
193199.
115. Malik, R. and Cross, G. (2003). Avian cryptococcosis. Med. Mycol. 41:115-124.
116. Manfredi, R., Fulgaro, C., Sabbatani, S., Legnani, G. and Fasulo, G. (2006). Emergence
of amphotericin B-resistant Cryptococcus laurentii meningoencephalitis shortly after
treatment for Cryptococcus neoformans meningitis in a patient with AIDS. AIDS Patient
Care STDs. 20:227–232.
117. McCarty, M. (1948). The occurrence of nucleases in culture of group A hemolytic
Streptococci. J. Exp. Med. 88:181–188.
118. Melo, J.C., Srinivasan, S., Scott, M.L. and Raff, M.J. (1980). Cryptococcus albidus
meningitis. J. Infect. 2:79-82.
119. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved
Guidelines. 2nd ed. 29(17); 2009. CLSI document M44-A2.
120. Meyer, W., Diaz, M.R. and Trilles, L. (2009). Consensus multilocus sequence typing
scheme for C. neoformans and C. gattii. Med. Mycol. 47:561-570.
121. Meyer, W., Huynh, M. and Castaneda, E. (2003). Molecular typing of Ibero American
Cryptococcus neoformans isolates. Emerg. Infect. Dis. 9:189-195.
122. Meyer, W., Lieckfeld, E., Kuhls, K., Freedman, E.Z., Borner, F. and Mitchell, T.G.
(1993). DNA and PCR fingerprinting in fungi. EXS. 67:311-320.
217
123. Meyer, W., Marszewska, K., Amirmostofina, M., Igreja, R.P., Hardtke, C., Methling, K.,
Viviani, M.A., Chindanporn, A., Sukroongreung, S., John, M.A., Ellis, D.H. and Sorrell,
T.C. (1999). Molecular typing of global isolates of Cryptococcus neoformans var.
neoformans by polymerase chain reaction fingerprinting and randomly amplified
polymorphic DNA - a pilot study to standardize techniques on which to base a detailed
epidemiological survey. Electroph. 20: 1790-1799.
124. Meyers, D.J., Palmer, K.C. and Bale, L.A. (1992). In vivo and in vitro toxicity of
phospholipase C from Pseudomonas aeruginosa. Toxicon. 30: 161-169.
125. Misra, V.C. and Randhawa, H.S. (2000). Occurrence and significance of Cryptococcus
neoformans in vegetables and fruits. Ind. J. Chest. Dis. All. Sci. 42:317-321.
126. Montenegro, H. and Paula, C.R. (2000). Environmental isolation of Cryptococcus
neoformans var. gattii and C. neoformans var. neoformans in the city of Sao Paulo,
Brazil. Med. Mycol. 38:385-390.
127. Morgan, J., Fan, K. and Brandt, M.E. (2006). Cryptococcus gattii infection:
characteristics and epidemiology of cases identified in a South African province with
high HIV seroprevalence, 2002- 2004. Clin. Infect. Dis. 43:1077-1080.
128. MTCC (Microbial Type Culture Collection) catalogue, IMTECH, Chandigarh. Available
from: http://mtcc.imtech.res.in/catalogue.php
129. Mukamurangwa, P., Wuytack, C. and Vroey, C. (1995). Cryptococcus neoformans var.
gattii can be separated from var. neoformans by its ability to assimilate D-tryptophan. J.
Med. Vet. Mycol. 33:419–420.
130. Muller, H.E. and Sethi, K.K. (1972). Proteolytic activity of Cryptococcus neoformans
against human plasma proteins. Med. Microbiol. Immunol. 158:129-134.
131. Muller, T., Philippi, N., Dandekar, T. and Schultz, J. (2007). Distinguishing species.
RNA. 13: 1469-1472.
218
132. Murray, P.A. (1999). Manual of Clinical Microbiology. 7th ed. Washington, D.C.: ASM
Press.
133. Narayan, S., Batta, K., Colloby, P. and Tan, C.Y. (2000). Cutaneous Cryptococcus
infection due to C. albidus associated with Sezary syndrome. Br. J. Dermatol.
143:632634.
134. Nishikawa, M.M., Lazera, M. and Wanke, B. (2003). Serotyping of 467 Cryptococcus
neoformans isolates from clinical and environmental sources in Brazil: analysis of host
and regional patterns. J. Clin. Microbiol. 41:73-77.
135. Nosanchuk, J.D. (2000). Evidence of Zoonotic transmission of Cryptococcus
neoformans from a pet cockatoo to an immunocompromised patient. Ann. Internal.
Med.132:205-208.
136. Odom, A., Muir, S., Lim, E. and Perfect, J. (1997). Calcineurin is required for virulence
of Cryptococcus neoformans. EMBO J. 16:2576-2589.
137. Olszewski, M.A., Noverr, M.C. and Chen, G.H. (2004). Urease expression by
Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing
central nervous system invasion. Am. J. Path. 164:1761–1771.
138. Park, B.J., Wannemuehler, K.A., Marston, B.J., Govender, N., Pappas, P.G. and Chiller,
T.M. (2009). Estimation of the current global burden of Cryptococcal meningitis among
persons living with HIV/AIDS. AIDS. 23:525–530.
139. Pedroso, R.S., Ferreira, J.C. and Candido, R.C. (2006). In vitro susceptibility to
antifungal agents of environmental Cryptococcus spp isolated in the city of Ribeirao
Preto, Sao Paulo, Brazil. Mem. d. Inst. Osw. Cruz. 101:239-243.
140. Perfect, J.R. and Casadevall, A. (2002). Cryptococcosis. Infect. Dis. Clin. N. Amer.
16:837-874.
219
141. Perfect, J.R. (2006). Cryptococcus neoformans: a sugar coated killer. In: Heitman, J., Eds.
Molecular principles of fungal pathogenesis. Washington, D.C.: ASM Press. 281– 303.
142. Polacheck, I. (1991). The discovery of melanin production in Cryptococcus neoformans
and its impact on diagnosis and the study of virulence. Zentralbl. Bakteriol. 276:120-
123.
143. Polacheck, I. and Kwon-Chung, K.J. (1980). Creatinine metabolism and Cryptococcus
neoformans and Cryptococcus bacillisporus. J. Bacteriol. 142:15-20.
144. Polacheck, I., Platt, Y. and Aronovitch, J. (1990). Catecholamines and virulence of
Cryptococcus neoformans. Infect. Immun. 58:2919-2922.
145. Polak, A. (1990). Melanin as a virulence factor in pathogenic fungi. Mycoses. 33:215–
224.
146. Price, M.F., Wilkinson, I.D. and Gently, L.O. (1982). Plate method for detection of
phospholipase activity in Candida albicans. Sabouraudia. 20: 7-14.
147. Pulverer, G. and Korth, H. (1971). Cryptococcus neoformans: Pigment bildung aus
verschiedenen Polyphenolen. Med. Microbiol. Immunol. 157:46-51.
148. Radford, D., Challacombe, S. and Walter, J. (1994). A scanning electron microscopy
investigation of the structure of colonies of different morphologies produced by
phenotypic switching in Candida albicans. J. Med. Microbiol. 40:416–423.
149. Ramchandren, R. and Gladstone, D.E. (2004). Cryptococcus albidus infection in a
patient undergoing autologous progenitor cell transplant. Transplantation. 77:956.
150. Randhawa, H.S., Kowshik, T. and Khan, Z.U. (2003). Decayed wood of Syzygium cumini
and Ficus religiosa living trees in Delhi metropolitan area as natural habitat of
Cryptococcus neoformans. Med. Mycol. 41:199-209.
220
151. Randhawa, H.S., Kowshik, T., Chowdhary, A., Khan, Z.U. and Xu, J. (2008). The
expanding host tree species spectrum of Cryptococcus gattii and Cryptococcus
neoformans and their isolations from surrounding soil in India. Med. Mycol. 46:823-833.
152. Randhawa, H.S., Mussa, A.Y. and Khan, Z.U. (2001). Decaying wood in tree trunk
hollows as a natural substrate for Cryptococcus neoformans and other yeast-like fungi of
clinical interest. Mycopathol. 151:63-69.
153. Rex, J.H., Pfaller, M.A., Walsh, T.J., Chaturvedi, V., Espinel-Ingroff, A. and Ghannoum,
M.A. (2001). Antifungal susceptibility testing: practical aspects and current challenges.
Clin. Microbiol. Rev. 14: 643–658.
154. Rhodes, J.C. and Roberts, G.D. (1975). Comparison of four methods for determining
nitrate utilization by Cryptococci. J. Clin. Microbiol. 1:9-10.
155. Rimek, D. (2004). First report of a case of meningitis caused by Cryptococcus adeliensis
in a patient with acute myeloid leukemia. J. Clin. Microbiol. 42:481–483.
156. Rippon, J.W. (1988). Medical Mycology. 3rd ed. Philadelphia: W.B. Saunders Co.
157. Roberts, G. (1985). Fungi. In J.A. Washington (ed.), Laboratory procedures in Clinical
Microbiology.2nd Ed. New York: Springer-Verlag. 419-500.
158. Ruiz, A., Fromtling, R.A. and Bulmer, G.S. (1981). Distribution of Cryptococcus
neoformans in a natural site. Infect. Immun. 31: 560–563.
159. Saitou, N. and Nei, M. (1987). The neighbor-joining method: A new method for
reconstructing phylogenetic trees. Mol. Bio. Evol.4:406-425.
160. Salkowski, C.A. and Balish, E. (1991). Cutaneous cryptococcosis in athymic and
beigeathymic mice. Infect. Immun. 59:1785-1789.
221
161. Saluja, P. and Prasad, G.S. (2007). Cryptococcus rajasthanensis sp. Nov., an anamorphic
yeast species related to Cryptococcus laurentii, isolated from Rajasthan, India. Int. J. Syst.
Evol. Microbiol. 57:414–418.
162. Sambrook, J. and Russel, D.W. (2001). Molecular cloning. A Laboratory Manual.
Volume 3. CSHL Press.
163. Schoch, C.L., Seifert, K.A., Huhndorf, S., Robert, V., Spouge, J.L., Levesque, C.A.,
Chen, W. and Fungal Bar-coding Consortium. (2011). Nuclear ribosomal internal
transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. PNAS
USA. 1-6 (Early edition).
164. Scorzetti, G., Fell, J.W., Fonseca, A. and Tallman, A. (2002). Systematics of
basidiomycetous yeasts: a comparison of large subunit D1/D2 and internal transcribed
spacer rDNA regions. FEMS Yeast Res. 2:495-517.
165. Seeliger, H.P.R. (1956). Use of a urease test for the screening and identification of
Cryptococci. Hygiene-Institut der Rheinischen Friedrich Wilhelms-Universitat.
52:127131.
166. Sharp, S.E. (2009). Cryptococcus gattii. Clin. Microbiol. NewsL. 31:84-86.
167. Shi, M., Li, S.S., Zheng, C., Jones, G.J., Kim, K.S., Zhou, H., Kubes, P. and Mody, C.H.
(2010). Real-time imaging of trapping and urease dependent transmigration of
Cryptococcus neoformans in mouse brain. J. Clin. Invest. 120:1683–1693.
168. Shinde, S.M., Vanarse, K.S. and Pandit, A.N. (2004). Systemic humicolus
cryptococcosis. Ind. Pediat. 41:1162-1164.
169. Sinha, H., Pain, A. and Johnstone, K. (2000). Analysis of the role of recA in phenotypic
switching of Pseudomonas tolaasii. J. Bacteriol. 182:6532–6535.
170. Slutsky, B., Buffo, J. and Soll, D.R. (1985). High-frequency switching of colony
morphology in Candida albicans. Science. 230:666–669.
222
171. Slutsky, B., Staebell, M., Anderson, J., Risen, L., Pfaller, M. and Soll, D.R. (1987).
“White-opaque transition‟‟: a second high-frequency switching system in Candida
albicans. J. Bacteriol. 169:189–197.
172. Sorrell, T.C. (2001). Cryptococcus neoformans variety gattii. Med. Mycol. 39:155-168.
173. Sorrell, T.C., Chen, S.C. and Brownlee, A.G. (1996). Concordance of clinical and
environmental isolates of Cryptococcus neoformans var. gattii by random amplification
of polymorphic DNA analysis and PCR fingerprinting. J. Clin. Microbiol. 34:1253-1260.
174. Springer, D.J. and Chaturvedi, V. (2010). Projecting global occurrence of Cryptococcus
gattii. Emerg. Infect. Dis. 16:14-20.
175. Staib, F., Seibold, M., Frolich, A.B., Weber, S. and Blisse, A. (1987). The brown colour
effect (BCE) of Cryptoccocus neoformans in the diagnosis, control and epidemiology of
C. neoformans infections in AIDS patients. Zentbl. Bakteriol. Microbiol. Hyg. 266:167–
177.
176. Stoddard, J.L. and Cutler, E.C. (1916). Torula infection in man. Waverly press, The
Williams and Wilkins co., Baltimore.
177. Sugita, T., Saito, M., Ito, T., Kato, Y., Tsuboi, R., Takeuchi, S. and Nishikawa, A. (2003).
The basidiomycetous yeasts Cryptococcus diffluens and C. liquefaciens colonize the skin
of patients with atopic dermatitis. Microbiol. Immunol. 47:945-950.
178. Sumby, P., Barbian, K.D., Gardner, D.J., Whitney, A.R., Welty, D.M. and Long, R.D.
(2005). Extracellular deoxyribonuclease made by group A Streptococcus assists
pathogenesis by enhancing evasion of the innate immune response. PNAS USA.
102:1679–1684.
179. Tamura, K., Nei, M. and Kumar, S. (2004). Prospects for inferring very large phylogenies
by using the neighbour-joining method. PNAS USA. 101:11030-11035.
223
180. Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M. and Kumar, S. (2011).
MEGA5: Molecular Evolutionary Genetics Analysis using Maximum Likelihood,
Evolutionary Distance, and Maximum Parsimony Methods. Mol. Bio. Evol.
181. Tintelnot, K. and Lostert, H. (2005). Isolation of Cryptococcus adeliensis from clinical
samples and the environment in Germany. J. Clin. Microbiol. 43:1007.
182. Trilles, L., Lazera, M. and Theelen, B. (2003). Genetic characterization of environmental
isolates of the Cryptococcus neoformans species complex from Brazil. Med. Mycol.
41:383-390.
183. UNAIDS. Report on the Global AIDS Epidemic. Available from:
http://data.unaids.org/pub/GlobalReport/2006/
184. Verma, A. and Kwon-Chung, K.J. (2010). Heteroresistance of Cryptococcus gattii to
fluconazole. Antimicrob. Agent. Chemother. 54:2303–2311.
185. Vidotto, V., Melhem, M., Pukinskas, S., Aoki, S., Carrara, C. and Pugliese, A. (2005).
Extracellular enzymatic activity and serotype of Cryptococcus neoformans strains
isolated from AIDS patients in Brazil. Rev. Iberoam. Micol. 22: 29-33.
186. Vilcins, I., Krockenberger, M., Aguand, H. and Carter, D.A. (2002). Environmental
sampling of Cryptococcus neoformans var. gattii from the Blue Mountains National
Park, Sydney, Australia. Med. Mycol. 40:53-60.
187. Vilgalys, R. and Hester, M. (1990). Rapid genetic identification and mapping of
enzymatically amplified ribosomal DNA from several Cryptococcus species. J.
Bacteriol. 172:4238-4246.
188. Viviani, M.A. and Cogliati, M. (2006). Molecular analysis of 311 Cryptococcus
neoformans isolates from a 30 month ECMM survey of cryptococcosis in Europe. FEMS
Yeast Res. 6:614-619.
224
189. Vlchkova-Lashkoska, M., Kamberova, S., Starova, A., Goleva-Mishevska, L.,
TsatsaBiljanovska, N., Janevska, V. and Petrovska, M. (2004). Cutaneous Cryptococcus
laurentii infection in a human immunodeficiency virus-negative subject. J. Eur. Acad.
Dermatol. Venereol. 18:99-100.
190. Wan, R., Wang, M., Zhao, S., Li, G., Zhou, Y., Li, J. and Du, J. (2011). A new
costeffective staining method for rapid identification of Cryptococcus. Afr. J. Microbiol.
Res. 5:1420-1427.
191. Wang, Y. and Casadevall, A. (1994). Growth of Cryptococcus neoformans in presence
of L-DOPA decreases its susceptibility to Amphotericin B. Antimicrob. Agent.
Chemother. 38:2648-2650.
192. Watson, K. (2002). Cryptococcus statzelliae sp. Nov. and three novel strains of
Cryptococcus victoriae, yeasts isolated from Antarctic soils. Int. J. Sys. Evol. Microbiol.
52:2303-2308.
193. Weather Report. Department of Environmental Science, College of Forestry. Dr YS
Parmar University of Horticulture & Forestry, Nauni (Solan), H.P. India.
194. White, T.J., Bruns, T., Lee, S. and Taylor, J. (1990). Amplification and direct sequencing
of fungal ribosomal RNA genes for phylogenetics. In: PCR Protocols: A Guide to
Methods and Application (Innis, M.A., Gelfand, D.H., Sninsky, J.J. and White, T.J.,
Eds.). 315-322. Academic Press, San Diego, CA.
195. Wickes, B.L., Mayorga, M.E., Edman, U. and Edman, J.C. (1996). Dimorphism and
haploid fruiting in Cryptococcus neoformans: association with the alpha-mating type.
PNAS USA. 93:7372-7381.
196. Williamson, P.R. (1994). Biochemical and molecular characterization of the diphenol
oxidase of Cryptococcus neoformans: identification as a laccase. J. Bacteriol.
176:656664.
225
197. Xu, J., Luo, G., Vilgalys, R.J., Brandt, M.E. and Mitchell, T.G. (2002). Multiple origins
of hybrid strains of Cryptococcus neoformans with serotype AD. Microbiol. 148:203212.
198. Yamamoto, Y., Kohno, S., Koga, H., Kaku, M. and Hara, K. (1995). Random amplified
polymorphic DNA analysis of clinically and environmentally isolated Cryptococcus
neoformans in Nagasaki. J. Clin. Microbiol. 33:3328-3332.